These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544 [TBL] [Abstract][Full Text] [Related]
29. Bioengineered living cardiac and venous valve replacements: current status and future prospects. Kehl D; Weber B; Hoerstrup SP Cardiovasc Pathol; 2016; 25(4):300-305. PubMed ID: 27167776 [TBL] [Abstract][Full Text] [Related]
30. Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves. James IA; Yi T; Tara S; Best CA; Stuber AJ; Shah KV; Austin BF; Sugiura T; Lee YU; Lincoln J; Trask AJ; Shinoka T; Breuer CK Tissue Eng Part C Methods; 2015 Sep; 21(9):987-94. PubMed ID: 25915105 [TBL] [Abstract][Full Text] [Related]
31. Mechanics of the pulmonary valve in the aortic position. Soares AL; van Geemen D; van den Bogaerdt AJ; Oomens CW; Bouten CV; Baaijens FP J Mech Behav Biomed Mater; 2014 Jan; 29():557-67. PubMed ID: 24035437 [TBL] [Abstract][Full Text] [Related]
33. Assessment of Parylene C Thin Films for Heart Valve Tissue Engineering. Marei I; Chester A; Carubelli I; Prodromakis T; Trantidou T; Yacoub MH Tissue Eng Part A; 2015 Oct; 21(19-20):2504-14. PubMed ID: 26101808 [TBL] [Abstract][Full Text] [Related]
34. A "sweet-spot" for fluid-induced oscillations in the conditioning of stem cell-based engineered heart valve tissues. Williams A; Nasim S; Salinas M; Moshkforoush A; Tsoukias N; Ramaswamy S J Biomech; 2017 Dec; 65():40-48. PubMed ID: 29054608 [TBL] [Abstract][Full Text] [Related]
35. A Tri-Leaflet Nitinol Mesh Scaffold for Engineering Heart Valves. Alavi SH; Soriano Baliarda M; Bonessio N; Valdevit L; Kheradvar A Ann Biomed Eng; 2017 Feb; 45(2):413-426. PubMed ID: 28008545 [TBL] [Abstract][Full Text] [Related]
36. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement. Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466 [TBL] [Abstract][Full Text] [Related]
37. Cyclic loading response of bioprosthetic heart valves: effects of fixation stress state on the collagen fiber architecture. Wells SM; Sellaro T; Sacks MS Biomaterials; 2005 May; 26(15):2611-9. PubMed ID: 15585264 [TBL] [Abstract][Full Text] [Related]
38. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Aikawa E; Whittaker P; Farber M; Mendelson K; Padera RF; Aikawa M; Schoen FJ Circulation; 2006 Mar; 113(10):1344-52. PubMed ID: 16534030 [TBL] [Abstract][Full Text] [Related]
39. Tissue-engineered heart valve with a tubular leaflet design for minimally invasive transcatheter implantation. Moreira R; Velz T; Alves N; Gesche VN; Malischewski A; Schmitz-Rode T; Frese J; Jockenhoevel S; Mela P Tissue Eng Part C Methods; 2015 Jun; 21(6):530-40. PubMed ID: 25380414 [TBL] [Abstract][Full Text] [Related]
40. Multiscale analysis of human tissue engineered matrices for next generation heart valve applications. Poulis N; Breitenstein P; Hofstede S; Hoerstrup SP; Emmert MY; Fioretta ES Acta Biomater; 2023 Mar; 158():101-114. PubMed ID: 36638939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]